87 related articles for article (PubMed ID: 3434006)
1. [Behavior the lipid spectrum following complete ovariectomy and subsequent substitution with estradiol valerate or norethisterone acetate].
Hempel E; Illessy G; Schubert KH
Zentralbl Gynakol; 1987; 109(21):1285-9. PubMed ID: 3434006
[TBL] [Abstract][Full Text] [Related]
2. [Serum lipids in treatment with transdermal estradiol and oral norethisterone acetate].
Mück AO; Salbach B; Rabe T; von Holst T; Runnebaum B
Geburtshilfe Frauenheilkd; 1995 Jul; 55(7):393-9. PubMed ID: 7557206
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of effects of estradiol in combination with either norethisterone acetate or trimegestone on lipids and lipoproteins in postmenopausal women.
Al-Azzawi F; Wahab M; Sami S; Proudler AJ; Thompson J; Stevenson J
Climacteric; 2004 Sep; 7(3):292-300. PubMed ID: 15669554
[TBL] [Abstract][Full Text] [Related]
4. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
Falkeborn M; Lithell H; Persson I; Vessby B; Naessén T
Climacteric; 2002 Sep; 5(3):240-8. PubMed ID: 12419082
[TBL] [Abstract][Full Text] [Related]
5. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
Ylikorkala O; Lim P; Caubel P
Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
[TBL] [Abstract][Full Text] [Related]
6. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
Odmark IS; Bäckström T; Haeger M; Jonsson B; Bixo M
Maturitas; 2004 Jun; 48(2):137-46. PubMed ID: 15172088
[TBL] [Abstract][Full Text] [Related]
7. Lipids and clotting factors during low dose transdermal estradiol/norethisterone use.
Brynhildsen J; Hammar M
Maturitas; 2005 Apr; 50(4):344-52. PubMed ID: 15780536
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
[TBL] [Abstract][Full Text] [Related]
9. Effect of norethisterone acetate on serum lipid and lipoprotein parameters as well as on blood coagulation in female monkeys (M. fascicularis).
Lehmann R; Bhargava AS; Kuhnz W; Freihube G; Günzel P
Contraception; 1993 Dec; 48(6):576-90. PubMed ID: 8131398
[TBL] [Abstract][Full Text] [Related]
10. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
[TBL] [Abstract][Full Text] [Related]
11. The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women.
Cano A; Calaf J; Molina J
Arch Gynecol Obstet; 2003 Oct; 268(4):317-22. PubMed ID: 14504877
[TBL] [Abstract][Full Text] [Related]
12. Postoperative serum levels of some fat metabolism parameters in women with uterine leiomyoma, depending on the extent of surgery.
Rzempoluch J; Kamiński BT; Wawryk R; Wiczkowski A; Dyla L; Sobolewska M
Zentralbl Gynakol; 1989; 111(14):960-6. PubMed ID: 2800780
[TBL] [Abstract][Full Text] [Related]
13. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipid and lipoprotein effects of transdermal administration of estradiol and estradiol/norethisterone acetate.
Lindgren R; Berg G; Hammar M; Larsson-Cohn U; Olsson AG
Eur J Obstet Gynecol Reprod Biol; 1992 Dec; 47(3):213-21. PubMed ID: 1294408
[TBL] [Abstract][Full Text] [Related]
15. The effect of 17β-estradiol plus norethisterone acetate treatment on the lipid profile in women: a dose-response meta-analysis of randomized controlled trials.
Abu-Zaid A; Gaman MA; Jamilian P; Ilesanmi-Oyelere BL; Jamilian P; Baradwan S; Bajaman JS; Alras KA; Kutbi E; Al-Ghrairi AKM; Sadulah DDS; Albazee E; Alomar O; Al-Badawi IA; Salem H
Exp Gerontol; 2022 Aug; 165():111855. PubMed ID: 35640782
[TBL] [Abstract][Full Text] [Related]
16. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
17. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
[TBL] [Abstract][Full Text] [Related]
18. Comparative clinical evaluation of the effect on carbohydrate and lipid metabolism of two norethisterone-containing hormonal contraceptives: Mesigyna and TriNovum.
Benagiano G; Primiero FM; Bastianelli C; Bianchi P; Medda E
Contraception; 1997 May; 55(5):295-300. PubMed ID: 9220226
[TBL] [Abstract][Full Text] [Related]
19. Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3.
Tuppurainen M; Heikkinen AM; Penttilä I; Saarikoski S
Maturitas; 1995 Jun; 22(1):55-61. PubMed ID: 7666817
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of low doses of ethinyl-estradiol on the lipid profile in postmenopausal women.
Minozzi M; Costabile L; Cosmi E; Donadio F; De Filippis E; Cosmi EV
Clin Exp Obstet Gynecol; 2001; 28(2):81-2. PubMed ID: 11491379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
